NCT02007655已完成不适用
Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation
Bristol-Myers Squibb1 个研究点 分布在 1 个国家目标入组 6,372 人开始时间: 2013年9月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 6,372
- 试验地点
- 1
- 主要终点
- Incidence rate of unexpected adverse events
研究概览
简要总结
The primary objectives of this study are:
- To estimate the incidence rate of unexpected adverse events
- To characterize the bleeding events and assess risk factors of bleeding
- To identify ancillary baseline variables that may also be associated with adverse outcomes
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who are beginning to receive the treatment with this product under the approved indications, dosage, and administration will be included in this study
排除标准
- •Patients who are receiving Eliquis outside of its approved indication will be excluded from this study
研究组 & 干预措施
Eliquis on Nonvalvular Atrial Fibrilliation patients
Patients who are beginning to receive the treatment with Eliquis under the approved indications, dosage, and administration will be included in this study
干预措施: Eliquis (Drug)
结局指标
主要结局
Incidence rate of unexpected adverse events
时间窗: 104 week (discontinuation)
Bleeding events and risk factors of bleeding
时间窗: 104 week (discontinuation)
Ancillary baseline variables that may also be associated with adverse outcomes
时间窗: 104 week (discontinuation)
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTEVenous ThromboembolismNCT02836457Bristol-Myers Squibb1,134
已完成
不适用
Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis CChronic Hepatitis CNCT02250001Bristol-Myers Squibb2,974
已完成
不适用
Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 DiabetesDiabetes Mellitus, Type 1DiabetesDiabetes Mellitus, Type 2NCT00700765Novo Nordisk A/S1,531
已完成
不适用
Paediatric Subjects - Special SurveyDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2NCT01538576Novo Nordisk A/S71
已完成
不适用
Special Survey for Paediatric SubjectsDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2NCT01487382Novo Nordisk A/S241